A practical reference on Lyophilized powder: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-12-06 and is reviewed periodically as new material appears.
The peptide emerged from research carried out in Saint Petersburg from the late 1980s onward, where investigators searched for shorter active fragments of a pineal preparation known as epithalamin. The name epitalon was chosen to reflect that parent extract. Early reports described effects on neuroendocrine markers and on the lifespan of laboratory animals. Much of that work appeared in Russian-language journals, with English translations following later, which affects how readily the original protocols can be assessed by outside groups.
Published studies on epitalon are dominated by a small number of research groups, and independent replication in other laboratories remains limited. Proposed mechanisms include activation of telomerase and modulation of melatonin rhythms, but the evidence for either rests mainly on cell cultures and animal models. Whether the peptide produces comparable effects in humans is an open question, and the absence of large controlled trials means the literature is best read as exploratory rather than settled.
Epitalon is a synthetic four-amino-acid peptide with the sequence alanine-glutamate-aspartate-glycine, commonly abbreviated AEDG. Its molecular formula is C14H22N4O9, and its calculated molar mass is approximately 390.35 grams per mole. The compound is a short fragment related to a peptide fraction isolated from bovine pineal gland extracts, and it is normally supplied as a lyophilised powder intended for laboratory research. It is not a registered pharmaceutical product in most countries.
Verification of a sample usually begins with reversed-phase high-performance liquid chromatography, which resolves the peptide from truncated sequences and other impurities and expresses purity as a percentage of total peak area. Mass spectrometry by electrospray ionisation or matrix-assisted laser desorption supplies an independent check, because the measured mass can be compared against the theoretical value for AEDG. Amino acid analysis or tandem mass spectrometry sequencing can confirm residue order. Each of these methods answers a different question: a purity figure does not establish identity, and an identity match does not establish how much of the material is intact peptide.
The molecule is a short, linear, hydrophilic peptide that dissolves readily in water or aqueous buffer. Its principal chemical liabilities are hydrolytic rather than oxidative, since it contains no cysteine, methionine, or tryptophan residues. The aspartate–glycine step is a recognised site for aspartimide formation under mildly acidic or basic conditions, generating isoaspartate and succinimide-related products over time. Desiccated lyophilised powder held at −20 °C is comparatively stable, whereas dilute solutions degrade faster and are best frozen as single-use aliquots rather than thawed repeatedly.
No pharmacopoeial monograph exists for this peptide, so quality rests on the supplier's internal specifications and on whatever independent testing a purchaser arranges. Certificates of analysis differ widely in which tests they report and in the limits applied. The counter-ion introduced during purification, commonly acetate or trifluoroacetate, changes the net peptide content of a given mass of powder, so two samples of equal weight may not contain equal amounts of the active sequence. Third-party laboratories can verify purity, identity, residual solvents, and counter-ion content for a fee, which makes documentation more informative than labelling.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C14H22N4O9 | Derived from the four-residue sequence |
| Molar mass | About 390.35 g/mol | Free peptide, counter-ion not included |
| Appearance | White to off-white powder | Lyophilised solid from aqueous solution |
| Water solubility | Freely soluble | Short, polar peptide chain |
| Common synonyms | AEDG; epithalone | Catalogues use the names interchangeably |
Interest in epitalon is usually discussed within the broader field of short peptide bioregulators, a category that includes other synthetic di-, tri-, and tetrapeptides studied by the same research group. These compounds share a common rationale: that small fragments of tissue-derived proteins can retain biological activity and can be produced reproducibly. The category as a whole remains outside mainstream pharmacological consensus, and epitalon specifically has a limited presence in independent, non-Russian research literature, which shapes how its evidence base is described.
Epitalon is a synthetic tetrapeptide with the amino acid sequence alanine-glutamate-aspartate-glycine, abbreviated Ala-Glu-Asp-Gly or AEDG. It was developed by the Russian researcher Vladimir Khavinson and colleagues during work on peptide bioregulators derived from the pineal gland. The compound is short enough to be produced by standard solid-phase peptide synthesis and is typically handled as a lyophilized white powder. Its small size distinguishes it from larger pineal peptides such as epithalamin, a complex extract from which the tetrapeptide was conceptually derived.
The four residues give epitalon a molecular formula of C14H22N4O9 and a molecular weight near 390.35 daltons. The presence of two acidic residues, glutamate and aspartate, makes the free peptide strongly acidic, while the alanine and glycine ends provide neutral, nonpolar character. This combination produces a molecule with substantial water solubility. Because there are no cysteine, methionine, or tryptophan residues, the peptide lacks the most common oxidation-sensitive side chains, which simplifies handling compared with many longer peptides.
Solubility is high in water, phosphate-buffered saline and normal saline, a pattern that follows from the two acidic residues in the chain. The peptide dissolves poorly in non-polar solvents such as hexane or chloroform. Stock solutions are often prepared in water first and then diluted into the buffer of interest. Because the molecule is small and hydrophilic, filtration through a low-protein-binding membrane is usually straightforward, and visible particulates are uncommon in freshly made solutions.
Identity and purity are established with reversed-phase high-performance liquid chromatography and mass spectrometry. The chromatogram shows the main peak and any truncated or oxidised by-products, while the mass spectrum confirms the expected 390 dalton mass. Amino acid analysis can corroborate composition when a sample's origin is uncertain. Counterion content, particularly residual trifluoroacetate from purification, is frequently reported alongside purity because it shifts the net mass of the solid.
Epitalon is a synthetic tetrapeptide with the sequence alanine-glutamate-aspartate-glycine, abbreviated AEDG. Its molecular formula is C14H22N4O9 and its calculated monoisotopic mass is approximately 390.35 daltons. The compound does not occur naturally as a free peptide; it is produced by solid-phase peptide synthesis. Because it contains two acidic residues and no basic residues, the neutral form carries a net negative charge at physiological pH. This charge profile influences how the peptide behaves in solution and during chromatographic analysis.
Laboratory-grade epitalon is typically supplied as a lyophilized powder. Purity is commonly assessed with reverse-phase high-performance liquid chromatography, often paired with mass spectrometry to confirm molecular identity. Amino acid analysis and peptide mapping can provide additional confirmation of sequence. Certificates of analysis for research materials frequently report purity above 95 percent, although the methods behind such figures vary between suppliers. The absence of a pharmacopeial monograph means that no single standardized assay defines the compound, so reported results depend on the analytical protocol chosen.
Storage recommendations center on limiting moisture, heat, and light. The dry powder is generally kept at minus 20 degrees Celsius, and some suppliers recommend minus 80 degrees for long-term archival. Once dissolved, solutions are usually aliquoted and frozen to avoid repeated freeze-thaw cycles, which can promote aggregation or degradation. Aqueous stability depends on pH and concentration, and buffered saline is often preferred over plain water for biological work. Stability data specific to epitalon remain limited, so general peptide-handling practices are applied by analogy rather than from product-specific validation.
Chiedozie Ngozi Egesi is a Nigerian plant scientist and professor. He is director of numerous research projects dedicated to international agriculture, gender equity and food and nutrition security in agriculture. He received the Achiever in Agriculture Award in 2021 by the Nigeria Agriculture Awards in 2021 and the Kwame Nkrumah Leadership Prize in 2022. Egesi grew up in a farming community in Umuahia South, Abia State. He received a Bachelor of Science from the University of Calabar in 1994 and a Master in Science on Environmental Biology at University of Ibadan in 1997. He earned a Ph.D in Agricultural Biology from University of Ibadan in 2001 He took certificate courses on Statistical Genetics at the University of Washington, Seattle, USA in 2007 and Spring class on Qualitative Trait Loci Analyses and Statistical Genetics at the Cornell University Ithaca, New York in April, 2012.
Healing her requires Gordon to make a dangerous trek through an Antlion colony to retrieve their "larval extract," an essential ingredient in the Vortigaunt healing process. As part of the healing process, her life is entwined with Gordon's. During this time, the G-Man appears to Gordon in a surreal "heart-to-heart" sequence and programs Alyx to tell her father to "prepare for unforeseen consequences." Once Alyx awakens, she and Gordon resume their quest toward White Forest. She delivers the Combine data to Dr. Kleiner, who manages to decrypt it and discover that Judith Mossman has found the legendary Borealis, an icebreaker ship which has disappeared during teleportation experiments. She delivers the message to her father after the G-Man triggers her programming, and later, two creatures called Advisors break in and kill Eli before Dog saves Gordon and Alyx. Alyx is the titular playable protagonist of the 2020 virtual reality game Half-Life: Alyx developed by Valve. The game follows a 19-year-old Alyx's story in City 17 five years before the events of Half-Life 2. Initially performing routine reconnaissance for the Resistance, Alyx is captured along with her father by the Combine after he discovers images relating to an apparent Combine superweapon called "the Vault." Russell, a Resistance mechanic, frees Alyx and sends her through the zombie-infested Quarantine Zone outside City 17 to rescue Eli. Along the way, Alyx meets an eccentric Vortigaunt who warns her of Eli's death in the future.
At least several thousand years ago, some humans developed a mutation in the MCM6 gene that keeps the LCT gene turned on even after breast feeding is stopped. Populations that are lactose intolerant lack this mutation. The LCT and MCM6 genes are both located on the long arm (q) of chromosome 2 in region 21. The locus can be expressed as 2q21. The lactase deficiency also could be linked to certain heritages and varies widely. A 2016 study of over 60,000 participants from 89 countries found regional prevalence of lactose malabsorption was "64% (54–74) in Asia (except Middle East), 47% (33–61) in eastern Europe, Russia, and former Soviet Republics, 38% (CI 18–57) in Latin America, 70% (57–83) in the Middle East, 66% (45–88) in northern Africa, 42% (13–71) in northern America, 45% (19–71) in Oceania, 63% (54–72) in sub-Saharan Africa, and 28% (19–37) in northern, southern and western Europe." According to Johns Hopkins Medicine, in the United States lactose intolerance is more common in Asian Americans, African Americans, Mexican Americans, and Native Americans. Analysis of the DNA of 94 ancient skeletons in Europe and Russia concluded that the mutation for lactose tolerance appeared about 4,300 years ago and spread throughout the European population. Some human populations have developed lactase persistence, in which lactase production continues into adulthood probably as a response to the benefits of being able to digest milk from farm animals.
Sources: en.wikipedia.org
=== Protein binding === Meropenem has a low protein binding rate of approximately 2%, in contrast to ertapenem, which is about 90%. This pharmacokinetic difference may impact clinical outcomes, particularly in hypoalbuminemic patients. Observational studies have shown that, in this population, treatment with meropenem is associated with a significantly lower 30-day mortality rate compared to ertapenem, with an approximately fourfold reduction in risk.
==== Methylation ==== Methylation of rRNA upholds structural rigidity by blocking base pair stacking and surrounds the 2'-OH group to block hydrolysis. It occurs at specific parts of eukaryotic rRNA. The template for methylation consists of 10-21 nucleotides. 2'-O-methylation of the ribose sugar is one of the most common rRNA modifications. Methylation is primarily introduced by small nucleolar RNA's, referred to as snoRNPs. There are two classes of snoRNPs that target methylation sites, and they are referred to box C/D and box H/ACA. One type of methylation, 2′-O-methylation, contributes to helical stabilization.
=== 2011–2016: The Devil Put Dinosaurs Here === On March 21, 2011, Alice in Chains announced that they were working on a fifth studio album, and both Cantrell and Inez later made statements that they had begun the recording process. The album was expected to be finished by summer of 2012 and released by the end of 2012 or beginning of 2013. While Alice in Chains were writing for the album in 2011, Cantrell underwent surgery on his right shoulder, which delayed recording the new material. In an interview published in May 2012, Cantrell explained, "The thing that set me back is I had some bone spurs [and] cartilage issues in my shoulders. I had the same issue in the other shoulder about six years ago so I've had them both done now. It's a repetitive motion injury from playing." Cantrell could not play guitar for eight months while he was recovering from surgery. While recuperating at home in a sling, Cantrell heard a riff in his head and sang it into his phone. The riff later became the song "Stone". Alice in Chains played their first concert in nearly 10 months and their first concert after Cantrell's shoulder surgery at the Winstar Casino in Thackerville, Oklahoma on August 13, 2011. The band's only concert in 2012 was a five-song acoustic set on May 31 at the eighth annual MusiCares MAP Fund Benefit Concert honoring Jerry Cantrell.
Sources: en.wikipedia.org
RNA polymerase Often abbreviated RNAP or RNApol. Any of a class of polymerase enzymes that synthesize RNA molecules from a DNA template. RNA polymerases are essential for transcription and are found in all living organisms and many viruses. They build long single-stranded polymers called transcripts by adding ribonucleotides one at a time in the 5'-to-3' direction, relying on the template provided by the complementary strand to transcribe the nucleotide sequence faithfully. Unlike DNA polymerases, RNA polymerases notably do not require oligonucleotide primers to initiate synthesis; i.e. they are capable of synthesizing RNA molecules de novo.
He prevailed over Etcheverry in four sets to reach his third consecutive semi-final at this tournament. He fell in his semi-final match to world No. 4 and last year finalist, Casper Ruud, in straight sets. Zverev began his grass season by withdrawing from the BOSS Open in Stuttgart due to a thigh injury that he picked up during his semifinal match at Roland Garros. Zverev then defeated Dominic Thiem, Denis Shapovalov, and Nicolas Jarry in Halle to reach the semifinals where he lost to eventual champion Alexander Bublik. At Wimbledon, Zverev lost in third round to Matteo Berrettini. In Båstad, Zverev lost in the quarterfinals to Andrey Rublev. Zverev won the Hamburg European Open, defeating Laslo Djere in the final. His triumph marked his 20th career ATP Title. During his 2023 US Open match against Jannik Sinner, Zverev halted play and complained to officials in response to a fan shouting the opening stanza to "Deutschlandlied", a song which has served as the national anthem of Germany; the use of the first and second stanza are presently commonly discouraged because of history. Alexander Zverev interpreted this as carrying Nazi sentiment and told officials that the fan had shouted, "the most famous Hitler phrase". Zverev lost the quarterfinals match against Carlos Alcaraz after winning a 4-hour 40 minutes five-set match against Jannik Sinner. This match, in combination with the Roland Garros 2023 semi-final, cemented Zverev's return to top form. His performance in the Asian swing was marked by his 21st title in Chengdu, defeating Roman Safiullin in three sets.
=== Disorders of plasma protein metabolism === 273 Disorders of plasma protein metabolism 273.0 Polyclonal hypergammaglobulinemia 273.1 Monoclonal paraproteinemia 273.2 Other paraproteinemias 273.3 Macroglobulinemia Waldenström macroglobulinemia 273.8 Other disorders of plasma protein metabolism Atransferrinemia
This is a conceptual leap that was quite different from Ibn al-Nafis' refinement of the anatomy and bloodflow in the heart and lungs." This work, with its essentially correct exposition, slowly convinced the medical world. However, Harvey was not able to identify the capillary system connecting arteries and veins; these were later discovered by Marcello Malpighi in 1661.
Sources: en.wikipedia.org
It is a synthetic tetrapeptide built from alanine, glutamate, aspartate and glycine. The four residues are joined by standard peptide bonds, giving a linear chain rather than a branched structure.
The name derives from epithalamin, a pineal gland extract studied in the former Soviet Union. Researchers proposed that short fragments of that extract carried the biological activity of interest.
No major regulatory agency has approved it as a medicine. It is handled as a research chemical, and products sold under this name are not standardised drugs with defined clinical labelling.
Mass spectrometry provides the identity check, because the observed mass is compared with the theoretical mass of the AEDG sequence. Chromatography separates and quantifies impurities but does not by itself prove which peptide is present. The two techniques are normally used together.